| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 3535- | MFrot, | MF, | Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications |
| - | Review, | Nor, | NA |
| 3492- | MFrot, | Chemo, | MF, | Synergistic Effect of Chemotherapy and Magnetomechanical Actuation of Fe-Cr-Nb-B Magnetic Particles on Cancer Cells |
| - | in-vitro, | Var, | NA |
| 3494- | MFrot, | MF, | Magnetically switchable mechano-chemotherapy for enhancing the death of tumour cells by overcoming drug-resistance |
| - | in-vitro, | Var, | NA |
| 3496- | MFrot, | GoldNP, | MF, | Enhancement of chemotherapy effects by non-lethal magneto-mechanical actuation of gold-coated magnetic nanoparticles |
| - | in-vitro, | Cerv, | HeLa |
| 2259- | MFrot, | MF, | Method and apparatus for oncomagnetic treatment |
| - | in-vitro, | GBM, | NA |
| 2262- | MFrot, | MF, | Effects of 0.4 T Rotating Magnetic Field Exposure on Density, Strength, Calcium and Metabolism of Rat Thigh Bones |
| - | in-vivo, | ostP, | NA |
| 2258- | MFrot, | MF, | EXTH-68. ONCOMAGNETIC TREATMENT SELECTIVELY KILLS GLIOMA CANCER CELLS BY INDUCING OXIDATIVE STRESS AND DNA DAMAGE |
| - | in-vitro, | GBM, | GBM | - | in-vitro, | Nor, | SVGp12 |
| 5243- | MFrot, | The assessment of the efficacy of the effect of a rotational magnetic field on the course of the tumor process in patients with generalized breast cancer |
| - | Human, | BC, | NA |
| 186- | MFrot, | MF, | Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields |
| - | in-vitro, | GBM, | GBM | - | in-vitro, | Lung, | NA |
| 229- | MFrot, | MF, | Molecular mechanism of effect of rotating constant magnetic field on organisms |
| - | in-vivo, | Nor, | NA |
| 188- | MFrot, | MF, | Spinning magnetic field patterns that cause oncolysis by oxidative stress in glioma cells |
| - | in-vitro, | GBM, | GBM115 | - | in-vitro, | GBM, | DIPG |
| 184- | MFrot, | MF, | Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells |
| - | in-vitro, | GBM, | GBM |
| 226- | MFrot, | MF, | Involvement of midkine expression in the inhibitory effects of low-frequency magnetic fields on cancer cells |
| - | in-vitro, | NA, | A549 | - | in-vitro, | NA, | LoVo |
| 215- | MFrot, | MF, | Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields |
| - | in-vitro, | PC, | CAF |
| 203- | MFrot, | MF, | Rotating Magnetic Field Induced Oscillation of Magnetic Particles for in vivo Mechanical Destruction of Malignant Glioma |
| - | vitro+vivo, | GBM, | U87MG |
| 516- | MFrot, | immuno, | MF, | Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth |
| - | vitro+vivo, | GBM, | U87MG |
| 8478- | MFrot, | Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity |
| - | vitro+vivo, | Lung, | NA |
| 8464- | Mg, | Cisplatin, | Efficacy of Prophylactic Magnesium Therapy for the Prevention of Cisplatin-Induced Renal Injury: A Meta-Analysis |
| - | Review, | Var, | NA |
| 8472- | Mg, | Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model |
| - | in-vivo, | AD, | NA |
| 8737- | MGO, | Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 |
| 1777- | MLT, | Melatonin as an antioxidant: under promises but over delivers |
| - | Review, | Var, | NA |
| 1778- | MLT, | Melatonin: a well-documented antioxidant with conditional pro-oxidant actions |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1779- | MLT, | Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review |
| - | Review, | BC, | NA |
| 1780- | MLT, | Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing |
| - | Review, | Var, | NA |
| 8656- | MLT, | Melatonin for sleep and cognitive outcomes in older adults with cognitive impairment: a meta-analysis of randomised controlled trials |
| - | Review, | Nor, | NA |
| 8663- | MLT, | Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect |
| - | vitro+vivo, | RCC, | 786-O |
| 8662- | MLT, | Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis |
| - | vitro+vivo, | Bladder, | 5637 | - | in-vitro, | CRC, | T24/HTB-9 | - | in-vitro, | HNSCC, | UM-SCC-1 |
| 8691- | MLT, | Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial |
| - | Trial, | Oral, | NA |
| 8690- | MLT, | Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells |
| - | vitro+vivo, | Gall, | NOZ |
| 8673- | MLT, | Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications |
| - | Review, | GC, | NA |
| 8683- | MLT, | Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment |
| - | in-vivo, | BC, | NA |
| 8676- | MLT, | Effect of melatonin on cognitive function in adults with cognitive impairment: a multi-dimensional meta-analysis of randomized trials |
| - | Review, | AD, | NA |
| 8674- | MLT, | Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial |
| - | Trial, | Var, | NA |
| 539- | MNPs, | Pulsed Magnetic Field Improves the Transport of Iron Oxide Nanoparticles through Cell Barriers |
| - | in-vitro, | NA, | NA |
| 8618- | MO, | Lemon Balm Extracts Prevent Breast Cancer Progression In Vitro and In Ovo on Chorioallantoic Membrane Assay |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 8610- | MO, | Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Colon, | T84 |
| 3845- | Moringa, | Protective effects of Moringa oleifera Lam. leaves against arsenic-induced toxicity in mice |
| - | in-vitro, | Nor, | NA |
| 3844- | Moringa, | Review of the Safety and Efficacy of Moringa oleifera |
| - | Review, | Nor, | NA |
| 3841- | Moringa, | Cerebroprotective effect of Moringa oleifera against focal ischemic stroke induced by middle cerebral artery occlusion |
| - | in-vivo, | Stroke, | NA |
| 3839- | Moringa, | Nutritional Value of Moringa oleifera Lam. Leaf Powder Extracts and Their Neuroprotective Effects via Antioxidative and Mitochondrial Regulation |
| - | in-vitro, | AD, | NA |
| 3838- | Moringa, | Characterization, Large-Scale HSCCC Separation and Neuroprotective Effects of Polyphenols from Moringa oleifera Leaves |
| - | in-vitro, | AD, | PC12 | - | Review, | Stroke, | NA |
| 8776- | MSM, | Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial |
| - | Trial, | Arthritis, | NA |
| 8775- | MSM, | Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells |
| - | Review, | Colon, | HCT116 |
| 3846- | MSM, | Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy |
| - | Human, | Nor, | NA |
| 3847- | MSM, | Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement |
| - | Review, | Arthritis, | NA |
| 8805- | MT/VAE, | Chemo, | Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL) |
| - | Trial, | PC, | NA |
| 8801- | MT/VAE, | A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings |
| - | Review, | Var, | NA |
| 2484- | mushLions, | Neurotrophic and Neuroprotective Effects of Hericium erinaceus |
| - | Review, | Stroke, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 1573- | MushReishi, | Ganoderma lucidum (Reishi mushroom) for cancer treatment |
| - | Review, | Var, | NA |
| 1997- | Myr, | QC, | Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity |
| - | in-vitro, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid